Ionis Pharmaceuticals, Inc.
Modulation of androgen receptor expression

Last updated:

Abstract:

Certain embodiments are directed to compounds and compositions targeted to human androgen receptor (AR) for inhibiting androgen receptor levels in a cell, which can be useful for methods of treating cancer and inhibiting cancer cell growth or proliferation.

Status:
Grant
Type:

Utility

Filling date:

13 Feb 2019

Issue date:

9 Mar 2021